If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,386.00    58.00 (1.34%)
Bid:
4,382.00
Ask:
4,388.00
Spread: 6.00 (0.137%)
Market Cap: £4.60b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

H1 2020 Trading Statement

22 Jul 2020 07:00

RNS Number : 6872T
Computacenter PLC
22 July 2020
 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSE OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) No. 596/2014.

 

FOR IMMEDIATE RELEASE

Computacenter plc

Trading Update - 22nd July 2020

Computacenter plc ("Computacenter" or the "Group"), a leading independent technology partner trusted by large corporate and public sector organisations, today publishes a trading update, based on unaudited financial information, for the period to 30 June 2020.

The Group's adjusted profit before tax in the first half of 2020 has turned out to be substantially ahead of the same period last year.

Whilst most of our industrial clients have been quiet, elsewhere there has been a surge in demand for IT equipment to enable home working which has considerably helped our performance, but this is only part of the story. Computacenter's customers have turned to our Services offerings and the skills of our people at what has been a challenging and demanding time for corporate IT functions. This is testament to the strength of our customer base; the relationships we have with those customers; and the value we deliver to them.

A reforecast of the second half of the year has been reviewed by the Board, which included the first confirmation that the Group's expected adjusted profitability in the second half of the year should be much improved on the forecast considered at the time of our Q1 2020 Trading Update on 23 April. This reforecast has provided better insight and improved clarity for the Board and, coupled with the very pleasing first half result, indicates a reduction in uncertainty in our markets for the second half of 2020. This allows the Board to provide meaningful guidance at this time concerning the second half of the year, notwithstanding the ongoing, and unpredictable, COVID-19 crisis.

Whilst for obvious reasons 2020 is a difficult year to predict, given the performance of the first half, which is behind us, the demand for our Services, the current Managed Services opportunity pipeline and the strength of our customer base, the Board believe that 2020, as a whole, will be a year of material progress for Computacenter, following a record-breaking 2019.

Computacenter's Board acknowledge, as is the case every year, that there is still a significant amount to do in the second half of the year and we look forward to giving more detail at the announcement of the Group's Interim Results on Wednesday 9 September 2020.

Enquiries:

Computacenter plc

Mike Norris, Chief Executive

+44 1707 631601

Tony Conophy, Finance Director

+44 1707 631515

Tulchan Communications

James Macey White

+44 20 7353 4200

Matt Low

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUMCMUPUPUG
Date   Source Headline
2nd Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSQ3 2022 Trading Update
20th Oct 202210:30 amRNSDirectorate Change
27th Sep 202212:00 pmRNSHolding(s) in Company
22nd Sep 202210:30 amRNSDirector/PDMR Shareholding
12th Sep 202212:00 pmRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSHalf-year Report
5th Aug 20229:30 amRNSBlock listing Interim Review
13th Jul 20227:00 amRNSAcquisition
19th May 20221:30 pmRNSResult of AGM
9th May 20225:30 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSQ1 2022 Trading Update
27th Apr 20229:03 amRNSCarbon Neutral Announcement
13th Apr 202212:15 pmRNS2021 Annual Financial Report & Notice of 2022 AGM
23rd Mar 20224:45 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results 2021
7th Feb 20229:49 amRNSBlock listing Interim Review
24th Jan 20227:00 amRNSPre-Close Trading Statement
12th Jan 20229:45 amRNSHolding(s) in Company
14th Dec 20214:45 pmRNSHolding(s) in Company
13th Dec 20215:00 pmRNSHolding(s) in Company
10th Dec 20212:00 pmRNSCompany Secretary Change
2nd Dec 20212:45 pmRNSDirector/PDMR Shareholding
15th Nov 202112:15 pmRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSQ3 2021 Trading Update
30th Sep 202112:00 pmRNSDirectorate Change
15th Sep 20214:25 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSTrading Statement
12th Aug 202112:00 pmRNSDirector Declaration
6th Aug 202111:15 amRNSBlock listing Interim Review
21st Jul 20217:00 amRNSTrading Statement
20th May 20211:00 pmRNSResult of AGM
30th Apr 20217:00 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSQ1 2021 Trading Update
20th Apr 20217:00 amRNS2020 Annual Report & Notice of 2021 AGM
24th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSFinal Results 2020
10th Mar 20217:00 amRNSDirectorate Change
5th Feb 20211:18 pmRNSBlock listing Interim Review
25th Jan 202111:45 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSPre-Close Trading Statement
4th Jan 20211:00 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSTrading Statement
10th Nov 20204:00 pmRNSPDMR/PCA Shareholding
30th Oct 20207:00 amRNSQ3 2020 Trading Update
27th Oct 20209:30 amRNSDirector/PDMR Shareholding
23rd Oct 20205:45 pmRNSApproval of Arrangement Agreement
16th Sep 202012:45 pmRNSDirector/PDMR Shareholding
15th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.